Call for new technologies

EuroGentest offers industry a unique network of accredited laboratories to evaluate new technologies. The next call for submissions is now underway.

Why?
New technologies in genetic testing are emerging rapidly. However their introduction and evaluation in diagnostic laboratories occurs ad hoc. The main aim of EuroGentest Unit 5 is to recruit the latest technological developments in genetic testing and to coordinate their technical evaluation in accredited Diagnostic Centres all over Europe with well-characterized clinical samples.

Who?
All companies, SME’s and research groups are invited to submit and introduce their latest test development for genome diagnostics and could get selected to present their new technique at the EuroGentest satellite meeting on 'Innovative Techniques in Genome Diagnostics' during the ESHG conference in Nice 2007.

What to do?
Therefore we now make a Call for Innovative Techniques in Genome Diagnostics at our Unit 5 homepage. We invite you to visit the Unit 5 homepage and look for further details.

Click here for the Unit 5 page

Then click on the "Call for Technologies" link

Previous Satellite meeting 2006.
On May 7, 2006 we had our first open meeting on 'New Techniques in Genome Diagnostics' at the European Society of Human Genetics Conference (ESHG) conference in Amsterdam. At this Satellite meeting speakers from prominent research groups and companies presented their latest data and initial experiences on new techniques in genetic testing to a large audience. Several interesting new approaches in genetic testing were introduced including, high-throughput mutation screening using High-Resolution Melting Curve Analysis (HR-MCA); Pyrophosphorolysis Activated Polymerization (PAP)-assay a very sensitive detection method for ultra rare mutations in the presence of excess wt allele; and genetic test applications using 3-D flow through microarray technology. Moreover, Gert Mathijs, co-leader of EuroGentest Unit 5, presented the first evaluation and initial validation results of the BRCA1-MLPA test (MRC-Holland) by the EuroGentest network of diagnostics laboratories. More details concerning our meeting and the evaluation projects that were initiated can be found at the “Call for New Technology” and "Current Test Trials" respectively of our Unit 5 Webpage.

Ongoing evaluation projects.
As a follow up to our first call in 2006 we have initiated several evaluation projects. Both the high-resolution melting curve analysis (HR-MCA) and Pyrophosphorolysis Activated Polymerization (PAP) technology are now being evaluated in a diagnostic setting of accredited laboratories. In addition we are evaluating the mutation scanning technique ‘Conformation sensitive capillary electrophoresis’ (CSCE) in collaboration with the NGRL in Wessex. More details concerning our evaluation projects can be found at the "Current Test Trials" of our Unit 5 Webpage

Images